Meitav Dash Investments LTD Keros Therapeutics, Inc. Transaction History

Meitav Dash Investments LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$37.26 - $51.01 $59,504 - $81,462	1,597 New	1,597 $64,000
Q2 2022 Aug 01, 2022	SELL	$26.03 - $67.04 $2.49 Million - $6.41 Million	-95,644 Reduced 84.55%	17,475 $482,000
Q1 2022 May 09, 2022	SELL	$42.12 - $59.36 $1.03 Million - $1.46 Million	-24,517 Reduced 17.81%	113,119 $6.15 Million
Q3 2021 Nov 03, 2021	BUY	$29.27 - $43.71 $4.03 Million - $6.02 Million	137,636 New	137,636 $5.45 Million

174

30.8M

62.7K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $263M
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Meitav Dash Investments LTD with notifications on news.